|Articles|September 13, 2012
Your Thoughts on day 5
We asked three ESCRS attendees how have they been inspired by this years ESCRS and here are their answers...
Advertisement
After attending this year's ESCRS have you been inspired to change your treatment protocol?
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
FLORetina 2025: New horizons in research and risk management for ROP
2
FLORetina 2025: Antithrombotic use examined in wet AMD submacular hemorrhage
3
FLORetina 2025: Enrico Borrelli on reframing retinal disease through the lens of choroidal health
4
FLORetina 2025: Remotely managing patients with neovascular age-related macular degeneration
5









































